Trial intelligence / Profile preview

Topiramate for BPD and Alcohol Dependence

NCT00463775Phase 3Withdrawn

Start
Mar 2007
Primary completion
May 2009
Modality
Small Molecules
01

Overview

A Phase 3 trial of topiramate in borderline personality disorder (BPD), alcohol dependence. Planned start Mar 2007; status: withdrawn.

02

Drugs

topiramate
03

Conditions

borderline personality disorder (BPD)alcohol dependence

Beyond the preview

Go deeper on NCT00463775.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00463775.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call